Magnesium Supplementation for Hypomagnesemia in Chronic Kidney Disease
Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
Randomized placebo-controlled interventional trial to investigate the effect of oral
magnesium supplementation on intracellular magnesium in subjects with chronic kidney disease.
We hypothesize that oral magnesium supplementation will increase intracellular magnesium in
subjects with chronic kidney disease as well as increase serum magnesium.